Image

Assessment of the NIPE in Very Premature Infant Ventilated and Sedated in Neonatal Reanimation.

Assessment of the NIPE in Very Premature Infant Ventilated and Sedated in Neonatal Reanimation.

Recruiting
7 years and younger
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

The Newborn Infant Parasympathetic Evaluation (NIPE) was developed as a method of analysis of the heart rate variability. The monitor gives a value between 0 (low value of the parasympathetic component) and 100 (high value of the parasympathetic component).

So far, the measure of the heart failure variability by using the NIPE in infant born very premature ventilated and sedated in neonatal reanimation has not been realised and validated as an evaluation method of the pain and discomfort related to neonatal care.

Eligibility

Inclusion Criteria:

  • Infant born very premature before 34 weeks of amenorrhoea + 0 day
  • Age ≤ 7 days
  • Admitted in neonatal reanimation
  • Sedated, intubated, ventilated

Exclusion Criteria:

  • High frequency oscillation ventilation
  • Heart rate non sinusal
  • Inotropes and atropine
  • Opposition from the guardian of parental authority
  • Difficulty of comprehension or communication making the parental information impossible

Study details
    Neonatal
    Pain Measurement
    Reanimation

NCT05223790

University Hospital, Lille

29 May 2024

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.